MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

MDT

98.84

+0.35%↑

144.96

-0.77%↓

VEEV

219.1

+0.44%↑

HQY

86.84

+1.35%↑

NEOG

9.45

+0.43%↑

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Затворен

2.13 4.93

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

2.07

Максимум

2.21

Ключови измерители
By Trading Economics
Служители	26

Дивиденти
By Dow Jones
Следващи печалби	26.02.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-4.6M 16M
Предишно отваряне	-2.8
Предишно затваряне	2.13

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

15.01.2026 г., 18:44 ч. UTC

Значими двигатели на пазара

Agenus Falls After $141 Million Zydus Deal Closes

15.01.2026 г., 17:51 ч. UTC

Значими двигатели на пазара

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

15.01.2026 г., 17:25 ч. UTC

Значими двигатели на пазара

ASML Exceeds $500 Billion in Market Value on TSMC's Blockbuster Spending Plans -- Update

15.01.2026 г., 23:48 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

15.01.2026 г., 23:48 ч. UTC

Пазарно говорене

Nikkei May Decline as Enthusiasm Over Election Eases -- Market Talk

15.01.2026 г., 23:40 ч. UTC

Пазарно говорене

Gold Edges Lower Amid Abating Geopolitical Risks -- Market Talk

15.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

15.01.2026 г., 23:11 ч. UTC

Пазарно говорене

Ryman Healthcare's Resales Remain Key Concern -- Market Talk

15.01.2026 г., 23:01 ч. UTC

Пазарно говорене

New Zealand's Economy Enters An Upswing -- Market Talk

15.01.2026 г., 22:56 ч. UTC

Пазарно говорене

Печалби

Catalyst Metals Delivers a Beat With Record Gold Output -- Market Talk

15.01.2026 г., 22:51 ч. UTC

Пазарно говорене

James Hardie's Plant Closures Could Boost Profit by 2%-3% -- Market Talk

15.01.2026 г., 22:19 ч. UTC

Придобивния, сливания и поглъщания

Verizon Gets Final California Approval to Secure $9.6 Billion Frontier Deal -- WSJ

15.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Печалби

Financial Services Roundup: Market Talk

15.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Energy & Utilities Roundup: Market Talk

15.01.2026 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

15.01.2026 г., 21:27 ч. UTC

Печалби

BlackRock Caps 2025 With Record $14 Trillion in Assets -- 3rd Update

15.01.2026 г., 21:15 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Commodities Roundup: Market Talk

15.01.2026 г., 21:11 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Global Equities Roundup: Market Talk

15.01.2026 г., 21:11 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Canada Antitrust Watchdog Confirms Review of Canadian Energy Deal -- Market Talk

15.01.2026 г., 20:10 ч. UTC

Пазарно говорене

U.S. Natural Gas Futures Settle Mixed -- Market Talk

15.01.2026 г., 20:04 ч. UTC

Печалби

These Stocks Are Today's Movers: TSMC, ASML, Goldman, Morgan Stanley, BlackRock, Coinbase, Sandisk, and More -- Barrons.com

15.01.2026 г., 20:03 ч. UTC

Пазарно говорене

Oil Futures Fall As Iran Risk Premium Fades -- Market Talk

15.01.2026 г., 19:26 ч. UTC

Пазарно говорене

Silver Closes at Fresh High -- Market Talk

15.01.2026 г., 18:29 ч. UTC

Значими двигатели на пазара

Agenus Falls After $141M Zydus Deal Closes

15.01.2026 г., 18:20 ч. UTC

Печалби

Wall Street Powers Nation's Biggest Banks to Record Year -- WSJ

15.01.2026 г., 17:56 ч. UTC

Пазарно говорене

Печалби

U.S. Bank Results Look Encouraging for European Peers -- Market Talk

15.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Auto & Transport Roundup: Market Talk

15.01.2026 г., 17:20 ч. UTC

Пазарно говорене

Health Care Roundup: Market Talk

15.01.2026 г., 17:15 ч. UTC

Пазарно говорене

Global Commodities Roundup: Market Talk

15.01.2026 г., 17:02 ч. UTC

Придобивния, сливания и поглъщания

KBC Group Completes Acquisition of 98.45% Stake in 365.bank From J&T Finance Group

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

0 ratings

Купи

Задържане

Продай

Според 0 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.